ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 992,59
0,39%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Stemline Therapeutics Inc (STML)

  7. Stemline Therapeutics Inc (STML) Actualités

STML

Stemline Therapeutics (STML)

Stemline Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:STML
DateHeureSourceTitreSymboleSociété
12/02/202122h18Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:STMLStemline Therapeutics Inc
22/06/202015h52Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:STMLStemline Therapeutics Inc
17/06/202012h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:STMLStemline Therapeutics Inc
10/06/202018h23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STMLStemline Therapeutics Inc
10/06/202017h51Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:STMLStemline Therapeutics Inc
10/06/202017h23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STMLStemline Therapeutics Inc
10/06/202016h20Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:STMLStemline Therapeutics Inc
10/06/202016h05Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:STMLStemline Therapeutics Inc
10/06/202016h05Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:STMLStemline Therapeutics Inc
10/06/202015h53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:STMLStemline Therapeutics Inc
15/05/202019h20PR Newswire (US)INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether the Following Mergers are Fair to Shareholders; Investors are Enco...NASDAQ:STMLStemline Therapeutics Inc
13/05/202020h43Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:STMLStemline Therapeutics Inc
12/05/202022h22Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:STMLStemline Therapeutics Inc
12/05/202021h14Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:STMLStemline Therapeutics Inc
11/05/202022h47Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:STMLStemline Therapeutics Inc
06/05/202001h57PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Stemline Therapeutics, Inc.NASDAQ:STMLStemline Therapeutics Inc
05/05/202020h23PR Newswire (US)Moore Kuehn Encourages TORC, STML, KLXE, and PTLA Investors to Contact Law FirmNASDAQ:STMLStemline Therapeutics Inc
05/05/202018h03Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:STMLStemline Therapeutics Inc
04/05/202021h09Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:STMLStemline Therapeutics Inc
04/05/202018h28PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Stemline Therapeutics Inc.NASDAQ:STMLStemline Therapeutics Inc
04/05/202017h22PR Newswire (US)Stemline Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether The Sale Of Stemline Therapeutics, Inc. ...NASDAQ:STMLStemline Therapeutics Inc
04/05/202016h58PR Newswire (US)Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Stemline Therapeutics Inc. has obtained a Fair Price in its sal...NASDAQ:STMLStemline Therapeutics Inc
04/05/202015h13PR Newswire (US)(STML) Alert: Johnson Fistel Investigates Proposed Sale of Stemline Therapeutics; Are Shareholders Getting a Fair Deal?NASDAQ:STMLStemline Therapeutics Inc
04/05/202013h00GlobeNewswire Inc.Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 MillionNASDAQ:STMLStemline Therapeutics Inc
29/04/202023h28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:STMLStemline Therapeutics Inc
29/04/202023h24Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:STMLStemline Therapeutics Inc
16/03/202022h05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:STMLStemline Therapeutics Inc
13/03/202021h45GlobeNewswire Inc.Stemline Therapeutics Reports Fourth Quarter 2019 Financial ResultsNASDAQ:STMLStemline Therapeutics Inc
11/03/202021h05GlobeNewswire Inc.Stemline Therapeutics to Host Conference Call on Fourth Quarter 2019 Financial Results on March 16, 2020NASDAQ:STMLStemline Therapeutics Inc
26/02/202013h30GlobeNewswire Inc.Stemline Therapeutics to Present at the Cowen 40th Annual Health Care ConferenceNASDAQ:STMLStemline Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:STML

Dernières Valeurs Consultées

USOTC
OKASY
Onward (PK)
NASDAQ
ACAX
Alset Capital Acquisition
USOTC
RLLMF
Real Matters (PK)
USOTC
HGGCF
Highway 50 Gold (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés